Persistent Expression of CD26/DPPIV After Treatment with Infliximab in Psoriasis Despite Clinical Improvement

Authors

  • Rosanne G. van Lingen
  • Piet E.J. van Erp
  • Marieke M.B. Seyger
  • Elke M.G.J. de Jong
  • Roelie T. de Boer-van Huizen
  • Rieke JB Driessen
  • Peter C.M. van de Kerkhof

DOI:

https://doi.org/10.2340/00015555-0675

Abstract

This article does not have an abstract.

Downloads

Download data is not yet available.

Downloads

Published

2009-08-05

How to Cite

van Lingen, R. G., van Erp, P. E., Seyger, M. M., de Jong, E. M., de Boer-van Huizen, R. T., JB Driessen, R., & van de Kerkhof, P. C. (2009). Persistent Expression of CD26/DPPIV After Treatment with Infliximab in Psoriasis Despite Clinical Improvement. Acta Dermato-Venereologica, 89(5), 518–520. https://doi.org/10.2340/00015555-0675

Issue

Vol. 89 No. 5 (2009)

Section

Articles

License

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC